Horne, Robert I. http://orcid.org/0000-0003-1534-2639
Andrzejewska, Ewa A. http://orcid.org/0000-0002-1421-5569
Alam, Parvez
Brotzakis, Z. Faidon
Srivastava, Ankit
Aubert, Alice
Nowinska, Magdalena
Gregory, Rebecca C.
Staats, Roxine
Possenti, Andrea
Chia, Sean
Sormanni, Pietro http://orcid.org/0000-0002-6228-2221
Ghetti, Bernardino
Caughey, Byron http://orcid.org/0000-0002-3928-6101
Knowles, Tuomas P. J. http://orcid.org/0000-0002-7879-0140
Vendruscolo, Michele http://orcid.org/0000-0002-3616-1610
Funding for this research was provided by:
UKRI
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (#AI001086, #AI001086, #AI001086)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RF1NS110437)
Article History
Received: 17 January 2023
Accepted: 12 February 2024
First Online: 17 April 2024
Competing interests
: R.I.H., M.N., S.C. and P.S. have been consultants of WaveBreak Therapeutics (formerly Wren Therapeutics). R.S. and A.P. have been employees of WaveBreak Therapeutics. M.V. and T.P.J.K. are founders of WaveBreak Therapeutics. WaveBreak Therapeutics is a company that seeks to identify therapeutics for neurodegeneration. The other authors declare no competing interests.